Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment
NCT05614765 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 18000
Last updated 2025-08-24
Summary
This study is a large-scale, prospective, multi-site, and non-interventional observational study to observe the change and safety of dyslipidemia management status when administering statin+etimib complex drugs in patients with dyslipidemia.
Conditions
- Dyslipidemias
Interventions
- DRUG
-
Statin+Ezetimibe compound
Crezet Tablet, Litorvazet Tablet
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Principal Investigators
-
JinWon Kim · Korea University Guro Hospital
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-08
- Primary Completion
- 2023-12-31
- Completion
- 2025-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)
NCT00157911 ·Status: COMPLETED ·Phase: PHASE3
-
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
NCT03874260 ·Status: UNKNOWN ·Phase: PHASE4
-
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
NCT00157924 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)
NCT00651274 ·Status: COMPLETED ·Phase: PHASE4
-
Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)
NCT00654095 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
NCT00651963 ·Status: COMPLETED ·Phase: PHASE4
-
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
NCT06293417 ·Status: RECRUITING ·Phase: NA
-
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
NCT00423579 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)
NCT00652327 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia
NCT05657574 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)
NCT00650819 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
NCT00423488 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
NCT02715726 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
NCT01674712 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
NCT02304926 ·Status: COMPLETED ·Phase: NA
-
To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
NCT06866509 ·Status: COMPLETED
-
LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
NCT01763866 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3015014 in Participants With High Cholesterol
NCT01890967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
NCT00479713 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.
NCT00256178 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
NCT00093899 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Therapy Results in the Real World Practice in the Czech Republic
NCT01055977 ·Status: COMPLETED
-
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
NCT00705211 ·Status: COMPLETED
-
Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )
NCT00408057 ·Status: COMPLETED
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3